Hyong Kim insider trades: Alignment Healthcare (ALHC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Hyong reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | ALHC | ↓ Sell | 32,479 | $8.30 | $270K | Direct | Oct 7, 2026 (1d) |
| Jun 12, 2026 | ALHC | ↓ Sell | 35,951 | $19.86 | $714K | Direct | Jun 15, 2026 (3d) |
| Jan 6, 2026 | ALHC | ↓ Sell | 16,506 | $21.35 | $352K | Direct | Jan 6, 2026 (0d) |
| Oct 9, 2025 | ALHC | ↓ Sell | 85,034 | $17.46 | $1.5M | Direct | Oct 10, 2025 (1d) |
| Aug 22, 2025 | ALHC | ↓ Sell | 24,800 | $16.00 | $397K | Direct | Aug 22, 2025 (0d) |
| Aug 13, 2025 | ALHC | ↓ Sell | 18,600 | $15.03 | $280K | Direct | Aug 15, 2025 (2d) |
| Aug 11, 2025 | ALHC | ↓ Sell | 18,600 | $14.54 | $270K | Direct | Aug 13, 2025 (2d) |
| Mar 20, 2025 | ALHC | ↓ Sell | 26,734 | $17.22 | $460K | Direct | Mar 21, 2025 (1d) |
| Mar 19, 2025 | ALHC | ↓ Sell | 8,266 | $16.40 | $136K | Direct | Mar 19, 2025 (0d) |
| Mar 7, 2025 | ALHC | ↓ Sell | 21,574 | $15.06 | $325K | Direct | Mar 7, 2025 (0d) |
| Mar 6, 2025 | ALHC | ↓ Sell | 21,020 | $15.65 | $329K | Direct | Mar 6, 2025 (0d) |
| Dec 5, 2024 | ALHC | ↓ Sell | 62,574 | $12.20 | $764K | Direct | Dec 6, 2024 (1d) |
| Oct 8, 2024 | ALHC | ↓ Sell | 22,460 | $11.03 | $248K | Direct | Oct 10, 2024 (2d) |
| Mar 19, 2024 | ALHC | ↓ Sell | 5,576 | $5.05 | $28K | Direct | Mar 21, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ALHC insiders
Open-market trades in the last 12 months
About Hyong Kim's insider trades
Hyong Kim is Chief Medical Officer at Alignment Healthcare (ALHC). Since Mar 19, 2024, Hyong has reported no open-market purchases and 14 sales worth $6.1M on SEC Form 4. In the last 12 months: 3 sales ($1.3M).
Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALHC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.